Drug reference
nivolumab
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Oncology (Monoclonal antibody(Oncology))
Mechanism of action
Monoclonal antibody to programmed cell death-1 protein (PD-1); blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2
Common side effects
- Pruritus
- Rash
- Cough
- Increased AST
- Hyponatremia
- Increased alkaline phosphatase
Related conditions
Frequently asked questions
What drug class is nivolumab?
nivolumab belongs to: Oncology.
How does nivolumab work?
Monoclonal antibody to programmed cell death-1 protein (PD-1); blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2
What are the common side effects of nivolumab?
Pruritus, Rash, Cough, Increased AST, Hyponatremia, Increased alkaline phosphatase
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.